We read every piece of feedback, and take your input very seriously. Include my email address so I can be contacted Cancel Submit feedback Saved searches Use saved searches to filter your results more quickly Cancel Create saved search Sign in Sign up Reseting focus {...
This study set out to query whether this statement is equivalent to there being no new reports of TdP events. Indeed it would be intuitive to expect that TdP (and other related ventricular conditions) might be observed to have decreased since introduction of these regulations. Therefore, an ...
Further to the Statement by directors pursuant to Section 169(15) of the Companies Act, 1965, the information set out in Note 44 on page 149 to the financial statements have been prepared in accordance with the Guidance on Special Matter No.1, Determination of Realised and Unrealised Profits ...
We incorporate by reference certain information from parts of our proxy statement for the 2017 Annual Meeting of Stockholders. The SEC allows us to disclose important information by referring to it in that manner. Please refer to such information. Our proxy statement for the 2018 Annual Meeting ...
Except as required by law, we do not undertake to update any forward-looking statement, whether written or oral, that may be made from time to time by us or on our behalf. Additional information about these and other factors can be found in the Risk, capital and liquidity management, ...
We encourage you to consider the risks below under the caption "—Risks Related to the Proposed Acquisition of Celgene" and the risk factors set forth in our registration statement on Form S-4 (Registration No. 333-229464), initially filed with the SEC on February 1, 2019 and subsequently ...